PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Researchers detail possible resistance mechanisms of colorectal cancer to bevacizumab (Avastin)

2013-10-29
(Press-News.org) Contact information: Garth Sundem
garth.sundem@ucdenver.edu
University of Colorado Denver
Researchers detail possible resistance mechanisms of colorectal cancer to bevacizumab (Avastin) A University of Colorado Cancer Center study published in the journal PLOS ONE shows that when colorectal cancer is targeted by the drug bevacizumab (Avastin), tumors may switch dependence from VEGF-A, which is targeted by the drug, to related growth factors in including VEGF-C, VEGF-D and placental growth factor. This change to new growth-factor dependence may allow colorectal cancer to push past bevacizumab's blockage of VEGF-A to continue to drive tumor growth.

"Think of it like damming a river. Bevacizumab can block the main flow, but then once a tumor's need builds up behind this dam, water starts to flow around the blockage in the form of streams and tributaries. That's like these other growth factors – eventually a tumor becomes able to use these tributaries of VEGF-C, VEGF-D and placental growth factor to supply itself with the 'water' it needs," says Christopher Lieu, MD, investigator at the CU Cancer Center and assistant professor of Medical Oncology at the University of Colorado School of Medicine.

The analogy of liquid is an apt one – bevacizumab slows cancer's growth by limiting a tumor's ability to grow the new blood vessels it needs to supply itself with nutrients. Especially in combination with chemotherapy, bevacizumab has proved an effective treatment for colorectal cancer. But then there frequently comes a point at which bevacizumab stops working and the tumor restarts its growth. This study asked why.

Specifically, Lieu and colleagues serially tested the levels of other VEGF-related growth factors in 42 patients treated with bevacizumab and chemotherapy, at many points during the course of their treatment.

"What we saw is that levels of VEGF-C and placental growth factor went up just before tumors progressed and then stayed high during the periods of tumor growth. Interestingly, VEGF-D was only elevated during progression. But it seems that tumors may be using these growth factors as ways to create blood vessel growth in the absence of VEGF-A, blocked by bevacizumab," Lieu says.

Then the researchers also took a snapshot of levels in 403 colorectal cancer patients, at one time during treatment. Because this group included patients who were and were not being treated with chemotherapy along with bevacizumab, they could show that the rise in VEGF levels was, in fact, due to bevacizumab and not to some interaction with the chemotherapy.

"It's too early to say with certainty that VEGF-C, VEGF-D, and placental growth factor are the cause of colorectal cancer resistance to bevacizumab, but the correlation we saw in this study is compelling," Lieu says.

Current studies are exploring the use of drugs that block more blood-vessel-growth-promoting factors than VEGF-A. For example, Lieu points to the example of aflibercept (Zaltrap), which was given FDA approval in August, 2013 for the treatment of metastatic colorectal cancer, along with the chemotherapy regimen known as FOLFIRI. The drug inhibits placental growth factor along with VEGF-A.

"It's an attractive strategy, and also proof of concept that by targeting not only the primary mechanism of tumor growth but also one or more of these 'workarounds,' this drug or other future drugs could stall growth longer than blocking any one of these growth factors, individually," Lieu says.

Lieu points out that in addition to targeting these additional growth factors, the fact that spikes in VEGF-C and placental growth factor presage tumor progression could give doctors and researchers a clue that bevacizumab has lost its efficacy. Though more work is needed, Lieu can imagine using spikes in VEGF-C or prenatal growth factor to recommend evaluating new treatment options.

INFORMATION:

END



ELSE PRESS RELEASES FROM THIS DATE:

U of M researchers identify key proteins influencing major immune strategies

2013-10-29
U of M researchers identify key proteins influencing major immune strategies Findings could help define new vaccination applications MINNEAPOLIS/ST. PAUL (October 27, 2013) – New research from the Masonic Cancer Center, University of Minnesota, ...

UT Dallas study shows experts' attitudes influence what children believe

2013-10-29
UT Dallas study shows experts' attitudes influence what children believe Children are more apt to believe a nice, non-expert than a mean expert according to researchers at The University of Texas at Dallas. In the study published in Developmental Science, ...

Microbiome in gut, mouth, and skin of low birth weight infants differentiate weeks after birth

2013-10-29
Microbiome in gut, mouth, and skin of low birth weight infants differentiate weeks after birth Low birth weight infants are host to numerous microorganisms immediately after birth, and the microbiomes of their mouths and gut start out very similar but differentiate ...

GW researchers examine increased ER reimbursements after ACA insurance coverage expansions

2013-10-29
GW researchers examine increased ER reimbursements after ACA insurance coverage expansions WASHINGTON (Oct. 28, 2013) – Researchers at the George Washington University School of Medicine and Health Sciences (SMHS) found that outpatient emergency department encounters ...

HIV -- Geneticists map human resistance to AIDS

2013-10-29
HIV -- Geneticists map human resistance to AIDS Do our genes hold the key to future AIDS therapies? Using a supercomputer, scientists analyzed the genomes of thousands of strains of the HIV virus and have produced the first map of human AIDS ...

Obamacare could reverse long trend of uncompensated care in ERs

2013-10-29
Obamacare could reverse long trend of uncompensated care in ERs WASHINGTON — Emergency departments, which have suffered shortfalls in reimbursement for decades due to the high rate of uninsurance in the United States, may begin receiving "considerably ...

People seem more attractive in a group than they do apart

2013-10-29
People seem more attractive in a group than they do apart People tend to be rated as more attractive when they're part of a group than when they're alone, according to findings published in Psychological Science, a journal of the Association ...

Study finds new genetic error in some lung cancers

2013-10-28
Study finds new genetic error in some lung cancers May offer target for therapies in patients BOSTON – A fine-grained scan of DNA in lung cancer cells has revealed a gene fusion – a forced merger of two normally separate genes – that spurs the cells to ...

Timely, effective treatment of rheumatoid arthritis reduces disability 2 years out

2013-10-28
Timely, effective treatment of rheumatoid arthritis reduces disability 2 years out Discouraging patients from delaying treatment could reduce disability from RA, according to study Delaying treatment for rheumatoid arthritis could greatly increase the likelihood ...

Study identifies biomarker linked to poor outcomes in pregnant lupus patients

2013-10-28
Study identifies biomarker linked to poor outcomes in pregnant lupus patients Researchers at Hospital for Special Surgery in New York City have identified a biomarker that may predict poor pregnancy outcomes in lupus patients. The study, titled "Angiogenic Factor ...

LAST 30 PRESS RELEASES:

Transnational electoral participation of undocumented Mexican immigrants in the US

A new method to build more energy-efficient memory devices for a sustainable data future

Freely levitating rotor spins out ultraprecise sensors for classical and quantum physics

‘Chinese lantern’ structure shifts into more than a dozen shapes for various applications

Towards light-controlled electronic components

Tiny architects, titanic climate impact: scientists call for October 10 to become International Coccolithophore Day

Stress sensitivity makes suicidal thoughts more extreme and persistent among the university population

Lessons from Ascension’s shark troubles could help boost conservation

Fire provides long-lasting benefits to bird populations in Sierra Nevada National Parks

Menstrual cycle affects women’s reaction time but not as much as being active

Housing associations more effective than government in supporting unemployed in deprived areas

Biochar helps composting go greener by cutting greenhouse gas emissions

Ulrich named president-elect of the AACI

Multitasking makes you more likely to fall for phishing emails

Researchers solve model that can improve sustainable design, groundwater management, nuclear waste storage, and more

Parched soils can spark hot drought a nation away

Uncovering new physics in metals manufacturing

Sped-up evolution may help bacteria take hold in gut microbiome, UCLA-led research team finds

The dose-dependent effects of dissolved biochar on C. elegans: Insights into the physiological and transcriptomic responses

New research reveals genetic link to most common pediatric bone cancer

Research conducted during 2024 eclipse reveals importance of light on bird behavior

Why does female fertility decline so fast? The key is the ovary

Total solar eclipse triggers dawn behavior in birds

Europe’s largest bats hunt and eat migrating birds on the wing, high in the sky

China’s emerging AI regulation could foster an open and safe future for AI

The secret to naked mole-rat’s longevity: Enhanced DNA repair

Acidic tumor environment promotes survival and growth of cancer cells

New biosensor tracks plants’ immune hormone in real time

New study finds gaps in REDD+ forest carbon offsets with most overstating climate impacts

Mystery solved: How Europe’s largest bat catches and eats passerines mid-air

[Press-News.org] Researchers detail possible resistance mechanisms of colorectal cancer to bevacizumab (Avastin)